US FDA's oversight of emerging technology is failing, says report
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration (FDA) lacks the scientific capacity to ensure the safety and effectiveness of emerging technologies, such as wireless healthcare devices, nanotechnology, medical imaging, robotics and combination products, according to a report released this week by the FDA's science board.